Biologically based dose response model for hepatic toxicity: A mechanistically based replacement for traditional estimates of noncancer risk

被引:19
作者
Conolly, RB
Butterworth, BE
机构
[1] Chemical Industry Institute of Toxicology, Research Triangle Park, NC 27709
关键词
chloroform; hepatotoxicity; quantitative; mechanism-based model; noncancer risk assessment; reduced uncertainty;
D O I
10.1016/0378-4274(95)03528-1
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Uncertainty in risk assessment can be reduced by increasing the use of relevant data specific to the particular xenobiotic and exposed organism. We describe the development of a preliminary, mechanism-based exposure response model for chloroform hepatotoxicity consisting of toxicokinetic (TR) and toxicodynamic (TD) submodels. The TK submodel is based on an existing physiologically based toxicokinetic (PBTK) model for chloroform. The TD submodel consists of an empirical function linking tissue dose, defined by the PBTK model, with hepatocyte killing and subsequent regenerative cellular replication. Chloroform-induced cell killing was inferred quantitatively from dose-response hepatic labelling index studies conducted in female B6C3F1 mice and male F344 rats. The overall model was scaled to humans by conventional scaling of the TK submodel and by using the TD submodel as is, i.e. as developed from the rodent data. The resulting human model was used to analyze a case of human poisoning which developed after repeated ingestion of large doses of cough syrup containing chloroform and alcohol. The model predicted the observed toxic response after the capacity for chloroform metabolism was increased by a factor of 3 from the value estimated using human liver microsomes. This is an acceptable adjustment of this parameter, given the uncertainty associated with the extrapolation from microsomes and the coexposure to alcohol. This preliminary result is encouraging, suggesting that the model, at its current stage of development, is able to approximate actual human risks of hepatotoxicity from chloroform exposure. The extensive use of data on chloroform TK and cytolethality-induced regenerative cellular replication for model development suggests that the model has reduced uncertainty relative to the current U.S. EPA oral reference dose (RfD) calculation for chloroform, which does not use any mechanistic or dose-response data.
引用
收藏
页码:901 / 906
页数:6
相关论文
共 11 条
[1]   DEVELOPMENT OF A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR CHLOROFORM [J].
CORLEY, RA ;
MENDRALA, AL ;
SMITH, FA ;
STAATS, DA ;
GARGAS, ML ;
CONOLLY, RB ;
ANDERSEN, ME ;
REITZ, RH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 103 (03) :512-527
[2]  
HEYWOOD R, 1979, J ENVIRON PATHOL TOX, V2, P835
[3]  
LAETHEM CL, 1994, ISSX P, V6, P270
[4]   INDUCED REGENERATIVE CELL-PROLIFERATION IN LIVERS AND KIDNEYS OF MALE F344 RATS GIVEN CHLOROFORM IN CORN-OIL BY GAVAGE OR AD-LIBITUM IN DRINKING-WATER [J].
LARSON, JL ;
WOLF, DC ;
BUTTERWORTH, BE .
TOXICOLOGY, 1995, 95 (1-3) :73-86
[5]   TOXICITY AND CELL-PROLIFERATION IN THE LIVER, KIDNEYS AND NASAL PASSAGES OF FEMALE F344 RATS, INDUCED BY CHLOROFORM ADMINISTERED BY GAVAGE [J].
LARSON, JL ;
WOLF, DC ;
MERY, S ;
MORGAN, KT ;
BUTTERWORTH, BE .
FOOD AND CHEMICAL TOXICOLOGY, 1995, 33 (06) :443-&
[6]   INDUCED CYTOLETHALITY AND REGENERATIVE CELL-PROLIFERATION IN THE LIVERS AND KIDNEYS OF MALE B6C3F(1) MICE GIVEN CHLOROFORM BY GAVAGE [J].
LARSON, JL ;
WOLF, DC ;
BUTTERWORTH, BE .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1994, 23 (04) :537-543
[7]   INDUCED CYTOTOXICITY AND CELL-PROLIFERATION IN THE HEPATOCARCINOGENICITY OF CHLOROFORM IN FEMALE B6C3F(1) MICE - COMPARISON OF ADMINISTRATION BY GAVAGE IN CORN-OIL VS AD-LIBITUM IN DRINKING-WATER [J].
LARSON, JL ;
WOLF, DC ;
BUTTERWORTH, BE .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1994, 22 (01) :90-102
[8]  
POLH L, 1979, REV BIOCHEM TOXICOL, V1, P79
[9]   ESTIMATING THE RISK OF LIVER-CANCER ASSOCIATED WITH HUMAN EXPOSURES TO CHLOROFORM USING PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING [J].
REITZ, RH ;
MENDRALA, AL ;
CORLEY, RA ;
QUAST, JF ;
GARGAS, ML ;
ANDERSEN, ME ;
STAATS, DA ;
CONOLLY, RB .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 105 (03) :443-459
[10]  
WALLACE C J, 1950, Calif Med, V73, P442